OSCR

Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC-LPC18:0 to suppress ferroptosis.

Overview

Authors: Zhen Li1,2, Jie Gao1, Jun Fu1,3, Xi Zhang1,3, Yiyang Zhou1,3, Chen Li1, Jutaek Nam2, Hongchang Gao1,3
  1. School of Pharmaceutical Sciences, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Institute of Metabonomics & Medical NMR, Wenzhou Medical University, Wenzhou, 325035 China
  2. College of Pharmacy, Chonnam National University, Gwangju, 61186 Republic of Korea
  3. Research and Experiment Center, Innovation Academy of Testing Technology, Wenzhou Medical University, Wenzhou, 325035 China
Institutions: Chonnam National University (South Korea); Wenzhou Medical University (China)
Journal: Molecular biomedicine, volume 7, issue 1, article 152
Dates: received 17 March 2026; accepted 2 August 2026; published online 26 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s43556-026-00546-w · PMID 42645726 · PMCID PMC13518694 · OpenAlex W7204257426
Open access: gold, a free copy (OpenAlex)
Categories: histology / microscopy (modality), human (organism), mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions
Keywords: Arachidonate 15-lipoxygenase, Phospholipase A2 group IVC, Lysophosphatidylcholine 18:0, Cognitive impairment
MeSH: Arachidonate 15-Lipoxygenase*, Cognitive Dysfunction*, Ferroptosis*, Gene Silencing*, Group IV Phospholipases A2*, Hypoxia*, Lysophosphatidylcholines*, Animals, Arachidonate 12-Lipoxygenase, Hippocampus, Humans, Lipid Peroxidation, Male, Mice, Mice, Inbred C57BL, Neurons (* major topic)
Topic: Ferroptosis and cancer prognosis (Cancer Research, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: National Research Foundation of Korea (RS-2025-00561884); National Natural Science Foundation of China (22274115)
Citations: not cited yet (Europe PMC); 55 references in the paper

Abstract

Hypoxic injury is a major contributor to cognitive impairment (CI), but the lipid metabolic mechanisms linking hypoxia (HYP) to hippocampal ferroptosis remain understood. This study investigated whether the arachidonate 15-lipoxygenase-cytosolic phospholipase A2 group IVC-lysophosphatidylcholine 18:0 (ALOX15-PLA2G4C-LPC18:0) axis contributes to HYP-induced hippocampal ferroptosis and CI. Morris water maze testing, Nissl staining, and NeuN immunofluorescence showed that HYP impaired spatial learning and memory and induced hippocampal neuronal loss in mice. Semi-targeted LC–MS/MS lipidomics revealed marked phospholipid/lysophospholipid (PL/LPL) remodeling, characterized by increased phosphatidylcholine and phosphatidylethanolamine species and decreased lysophosphatidylcholine species, particularly LPC18:0. Ferroptosis-related biochemical assays and transmission electron microscopy further demonstrated glutathione (GSH) depletion, malondialdehyde (MDA) accumulation, glutathione peroxidase 4 (GPX4) downregulation, and mitochondrial abnormalities. GEO dataset analysis, qRT-PCR, and Western blotting identified ALOX15 as a HYP-responsive ferroptosis-associated regulator. Hippocampal AAV-mediated Alox15 knockdown improved cognitive performance, preserved hippocampal neurons, suppressed lipid peroxidation, and partially restored PL/LPL homeostasis. In HYP-exposed SH-SY5Y cells, genetic and pharmacological experiments further supported the contribution of ALOX15 to ferroptosis-related injury. RNA sequencing, promoter-reporter assays, and gain- and loss-of-function experiments suggested that ALOX15 suppressed PLA2G4C expression partly through MAFK-dependent transcriptional modulation. PLA2G4C restoration increased LPC18:0 production, whereas LPC18:0 supplementation attenuated ferroptosis-related injury and improved hippocampal pathology and cognitive performance in HYP-exposed mice. Collectively, these findings support the ALOX15-PLA2G4C-LPC18:0 axis as a potential lipid-remodeling mechanism underlying HYP-induced hippocampal ferroptosis and highlight ALOX15 inhibition and LPC18:0 restoration as potential strategies for mitigating HYP-induced CI.

Supplementary Information: The online version contains supplementary material available at 10.1186/s43556-026-00546-w.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The metabolomics data are available in Synapse under Project SynID syn75980291. The transcriptome sequencing data are available in NCBI under accession number PRJNA1477317.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 4 keywords, 16 MeSH terms, 2 funders, 55 references.

Cite

This paper

Li, Z., Gao, J., Fu, J., Zhang, X., Zhou, Y., Li, C., Nam, J., & Gao, H. (2026). Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC-LPC18:0 to suppress ferroptosis. Molecular biomedicine, 7(1), 152. https://doi.org/10.1186/s43556-026-00546-w

BibTeX

@article{li2026silencing,
author = {Li, Zhen and Gao, Jie and Fu, Jun and Zhang, Xi and Zhou, Yiyang and Li, Chen and Nam, Jutaek and Gao, Hongchang},
title = {{Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC-LPC18:0 to suppress ferroptosis}},
journal = {Molecular biomedicine},
year = {2026},
month = aug,
volume = {7},
number = {1},
pages = {152},
publisher = {Springer},
issn = {2662-8651},
doi = {10.1186/s43556-026-00546-w},
url = {https://doi.org/10.1186/s43556-026-00546-w},
pmid = {42645726},
pmcid = {PMC13518694}
}

RIS

TY - JOUR
AU - Li, Zhen
AU - Gao, Jie
AU - Fu, Jun
AU - Zhang, Xi
AU - Zhou, Yiyang
AU - Li, Chen
AU - Nam, Jutaek
AU - Gao, Hongchang
TI - Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC-LPC18:0 to suppress ferroptosis
T2 - Molecular biomedicine
J2 - Mol Biomed
PY - 2026
DA - 2026/08/26
VL - 7
IS - 1
SP - 152
SN - 2662-8651
PB - Springer
DO - 10.1186/s43556-026-00546-w
UR - https://doi.org/10.1186/s43556-026-00546-w
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s43556-026-00546-w",
"type": "article-journal",
"title": "Silencing arachidonate 15-lipoxygenase alleviates hypoxia-induced cognitive impairment through the mediation of phospholipase A2 group IVC-LPC18:0 to suppress ferroptosis",
"container-title": "Molecular biomedicine",
"author": [
{
"family": "Li",
"given": "Zhen"
},
{
"family": "Gao",
"given": "Jie"
},
{
"family": "Fu",
"given": "Jun"
},
{
"family": "Zhang",
"given": "Xi"
},
{
"family": "Zhou",
"given": "Yiyang"
},
{
"family": "Li",
"given": "Chen"
},
{
"family": "Nam",
"given": "Jutaek"
},
{
"family": "Gao",
"given": "Hongchang"
}
],
"container-title-short": "Mol Biomed",
"volume": "7",
"issue": "1",
"page": "152",
"DOI": "10.1186/s43556-026-00546-w",
"PMID": "42645726",
"PMCID": "PMC13518694",
"ISSN": "2662-8651",
"publisher": "Springer",
"URL": "https://doi.org/10.1186/s43556-026-00546-w",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
26
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12915-025-02235-6
Transcriptomic signatures of oxytosis/ferroptosis are enriched in Alzheimer's disease.
Journal: BMC biology
In common: Alzheimer's / dementia, mouse, cellular / molecular, 3 references
[2] doi:10.1186/s12864-023-09188-6
Brain fatty acid and transcriptome profiles of pig fed diets with different levels of soybean oil.
Journal: BMC genomics
In common: cellular / molecular, 3 references
[3] doi:10.1038/s41593-022-01221-3
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration.
Journal: Nature neuroscience
In common: cellular / molecular, 3 references
[4] doi:10.62641/aep.v52i6.1740
Identification and Correlation Analysis of Ferroptosis-Related Genes in Three Brain Regions of Patients with Schizophrenia.
Journal: Actas espanolas de psiquiatria
In common: histology / microscopy, cellular / molecular, 3 references
[5] doi:10.3389/fcell.2022.843297
Transcriptome Profiles of IncRNA and mRNA Highlight the Role of Ferroptosis in Chronic Neuropathic Pain With Memory Impairment.
Journal: Frontiers in cell and developmental biology
In common: histology / microscopy, cellular / molecular, 3 references
[6] doi:10.1016/j.redox.2023.102982
IL-10 protects against OPC ferroptosis by regulating lipid reactive oxygen species levels post stroke.
Journal: Redox biology
In common: mouse, cellular / molecular, 3 references
[7] doi:10.3390/antiox11020189
Protective Effect of GIP against Monosodium Glutamate-Induced Ferroptosis in Mouse Hippocampal HT-22 Cells through the MAPK Signaling Pathway.
Journal: Antioxidants (Basel, Switzerland)
In common: mouse, cellular / molecular, 3 references
[8] doi:10.1038/s41419-025-08147-1
Chr:17q21.31 locus risk haplotype H1 susceptibility to ferroptosis is mediated by endolysosomal pathway.
Journal: Cell death & disease
In common: cellular / molecular, 3 references
[9] doi:10.1038/s41467-026-68325-3 [code]
Glycerol 3-phosphate acyltransferase exacerbates α-synuclein-induced toxicity by increasing lipid peroxidation.
Journal: Nature communications
In common: mouse, cellular / molecular, 2 references
[10] doi:10.3389/fnagi.2022.970796
Exploring the key ferroptosis-related gene in the peripheral blood of patients with Alzheimer's disease and its clinical significance.
Journal: Frontiers in aging neuroscience
In common: Alzheimer's / dementia, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.